Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Methods (San Diego, Calif.)
|
April 26, 2011
Enzymatic assays for assessing histone deubiquitylation activity
Robyn T Sussman, Xiao-Yong Zhang, Steven B McMahon
Cancer Genetics
|
December 31, 2021
NTRK point mutations and their functional consequences
Corey Rogers, Jennifer J D Morrissette, Robyn T Sussman
The American Journal of Surgical Pathology
|
August 11, 2020
Primary Pulmonary Myxoid Sarcoma and Myxoid Angiomatoid Fibrous Histiocytoma: A Unifying Continuum With Shared and Distinct Features
Hongxing Gui, Robyn T Sussman, Bo Jian, et al.
Cancer Biology & Therapy
|
September 21, 2007
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Robyn T Sussman, M Stacey Ricci, Lori S Hart, et al.
The Journal of Biological Chemistry
|
June 14, 2013
The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2)
Robyn T Sussman, Timothy J Stanek, Paul Esteso, et al.
Archives of Pathology & Laboratory Medicine
|
June 19, 2019
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms
Robyn T Sussman, Amanda R Oran, Carmela Paolillo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 23, 2021
Correction: Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice
Adam R Davis, Sara L Stone, Amanda R Oran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 14, 2020
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice
Adam R Davis, Sara L Stone, Amanda R Oran, et al.
Mabs
|
February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Yang Feng, Yanping Wang, Zhongyu Zhu, et al.
Cancer Genetics
|
April 29, 2021
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML
Robyn T Sussman, Bryan Manning, Daniel Ackerman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Methods (San Diego, Calif.)
|
April 26, 2011
Enzymatic assays for assessing histone deubiquitylation activity
Robyn T Sussman, Xiao-Yong Zhang, Steven B McMahon
Cancer Genetics
|
December 31, 2021
NTRK point mutations and their functional consequences
Corey Rogers, Jennifer J D Morrissette, Robyn T Sussman
The American Journal of Surgical Pathology
|
August 11, 2020
Primary Pulmonary Myxoid Sarcoma and Myxoid Angiomatoid Fibrous Histiocytoma: A Unifying Continuum With Shared and Distinct Features
Hongxing Gui, Robyn T Sussman, Bo Jian, et al.
Cancer Biology & Therapy
|
September 21, 2007
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Robyn T Sussman, M Stacey Ricci, Lori S Hart, et al.
The Journal of Biological Chemistry
|
June 14, 2013
The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2)
Robyn T Sussman, Timothy J Stanek, Paul Esteso, et al.
Archives of Pathology & Laboratory Medicine
|
June 19, 2019
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms
Robyn T Sussman, Amanda R Oran, Carmela Paolillo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 23, 2021
Correction: Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice
Adam R Davis, Sara L Stone, Amanda R Oran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 14, 2020
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice
Adam R Davis, Sara L Stone, Amanda R Oran, et al.
Mabs
|
February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Yang Feng, Yanping Wang, Zhongyu Zhu, et al.
Cancer Genetics
|
April 29, 2021
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML
Robyn T Sussman, Bryan Manning, Daniel Ackerman, et al.
Page
of 2